Westfield Capital Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,994,589
Closed -$38.5M 257
2024
Q3
$38.5M Sell
1,994,589
-684,648
-26% -$12.6M 0.17% 154
2024
Q2
$43.9M Buy
2,679,237
+567,574
+27% +$8.81M 0.22% 145
2024
Q1
$32.2M Sell
2,111,663
-502,464
-19% -$7.89M 0.17% 176
2023
Q4
$41.9M Buy
2,614,127
+569,117
+28% +$7.96M 0.24% 150
2023
Q3
$26.6M Buy
2,045,010
+127,759
+7% +$1.66M 0.18% 160
2023
Q2
$24.4M Buy
1,917,251
+157,820
+9% +$1.98M 0.16% 164
2023
Q1
$19.8M Sell
1,759,431
-2,346,705
-57% -$28.5M 0.14% 167
2022
Q4
$54.4M Buy
4,106,136
+145,968
+4% +$1.92M 0.42% 98
2022
Q3
$46M Buy
3,960,168
+528,481
+15% +$7.25M 0.37% 106
2022
Q2
$50.7M Buy
3,431,687
+480,175
+16% +$7.87M 0.4% 93
2022
Q1
$57.1M Sell
2,951,512
-731,973
-20% -$13.1M 0.37% 97
2021
Q4
$63.5M Buy
3,683,485
+186,640
+5% +$3.18M 0.38% 93
2021
Q3
$58.4M Buy
3,496,845
+426,436
+14% +$6.38M 0.35% 105
2021
Q2
$41.2M Buy
3,070,409
+798,130
+35% +$9.99M 0.25% 138
2021
Q1
$27.2M Buy
2,272,279
+1,434,228
+171% +$17.3M 0.17% 155
2020
Q4
$10.4M Buy
+838,051
New +$9.04M 0.06% 192

Other funds holding INVA

Westfield Capital Management's INVA Position: Q4 2024 in Review

Westfield Capital Management sold out of Innoviva (INVA) in Q4 2024, closing a stake of 1,994,589 shares — an estimated $38.5M sold.

Westfield Capital Management first reported a position in INVA in Q4 2020 and held it in 16 quarters. The position peaked at $63.5M in Q4 2021. 235 funds tracked by Wall St. Rank hold INVA as of Q4 2024.

  • Westfield Capital Management reported no remaining Innoviva position as of Q4 2024 after selling out during the quarter.
  • Westfield Capital Management sold 1,994,589 Innoviva shares in Q4 2024, an estimated $38.5M.
  • Westfield Capital Management first reported a position in Innoviva in Q4 2020 and held it in 16 quarters.
  • Westfield Capital Management's Innoviva position peaked at $63.5M in Q4 2021.
  • 235 funds tracked by Wall St. Rank held Innoviva as of Q4 2024.

Based on Westfield Capital Management's 13F filing for Q4 2024, filed 11 Feb 2025.